NetworkNewsBreaks – FinCanna Capital Corp. (CSE:
Post# of 30

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that its investee company, Refined Resin Technologies Inc., has attained its second purchase order for THC distillate in the minimum amount of $9.6 million, bringing its total purchase orders to $10.4 million. The order was received from a prominent, large volume, California cannabis enterprise and specifies $9.6 million as a minimum annual amount, contingent to consistent delivery and performance. “This multimillion-dollar order from an industry leading distributor illustrates the outstanding reputation and confidence in the Refined Resin team from leading players in the California market,” FinCanna Capital President and CEO Andriyko Herchak stated in the news release. “We see this trend continuing as the Refined Resin team has a deep network and a known industry standard to deliver a high-quality THC distillate.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

